Faron Pharmaceuticals Oy (LSE:FARN) Other Stockholders Equity : £132.98 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Faron Pharmaceuticals Oy Other Stockholders Equity?

Faron Pharmaceuticals Oy's Other Stockholders Equity for the quarter that ended in Dec. 2023 was £132.98 Mil.

Faron Pharmaceuticals Oy's quarterly Other Stockholders Equity increased from Dec. 2022 (£112.67 Mil) to Jun. 2023 (£124.23 Mil) and increased from Jun. 2023 (£124.23 Mil) to Dec. 2023 (£132.98 Mil).

Faron Pharmaceuticals Oy's annual Other Stockholders Equity increased from Dec. 2021 (£98.99 Mil) to Dec. 2022 (£112.67 Mil) and increased from Dec. 2022 (£112.67 Mil) to Dec. 2023 (£132.98 Mil).

Faron Pharmaceuticals Oy Other Stockholders Equity Historical Data

The historical data trend for Faron Pharmaceuticals Oy's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Faron Pharmaceuticals Oy Other Stockholders Equity Chart

Faron Pharmaceuticals Oy Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

66.90

83.29

98.99

112.67

132.98

Faron Pharmaceuticals Oy Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Stockholders Equity	Get a 7-Day Free Trial															98.99	103.72	112.67	124.23	132.98

Faron Pharmaceuticals Oy Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Faron Pharmaceuticals Oy Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Faron Pharmaceuticals Oy's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Faron Pharmaceuticals Oy (LSE:FARN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Faron Pharmaceuticals Oy (LSE:FARN) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

FARON:Finland 4FR:Germany

Address

Joukahaisenkatu 6 B, Turku, FIN, 20520

Website

https://www.faron.com

Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical company developing novel treatments for medical conditions with unmet needs. The company has a pipeline based on the receptors involved in the regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy in phase I/II development as a novel macrophage checkpoint immunotherapy for patients with untreatable solid tumours, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation. Traumakine, the company's investigational intravenous interferon beta-1a is an anti-viral and anti-inflammatory agent, being tested in several Phase III studies around the world against COVID-19.

Faron Pharmaceuticals Oy (LSE:FARN) Headlines

No Headlines